Diagnostic dilemmas in detection of prostate cancer in patients undergoing transrectal ultrasound-guided needle biopsy of the prostate

Prostate Cancer and Prostatic Diseases

Volumn 3, Issue 1, 2000, Pages 13-20

  Durkan, G C ^a   Greene, D R ^a  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

Biopsy; Diagnosis; Prostate neoplasms; Transrectal ultrasound

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER TISSUE; HEMATURIA; HEMOSPERMIA; HUMAN; HUMAN TISSUE; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT INDICATION; TUMOR BIOPSY;

EID: 0033858645     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500398     Document Type: Review

References (69)

1. Cancer statistics
2. The changing pattern of prostate cancer at the time of diagnosis: Characteristics of screen detected prostate cancer in a population based screening study
3. The prostate cancer intervention versus observation trial: A randomised trial comparing radical prostatectomy vs expectant management for the treatment of clinically localised prostate cancer
4. Prostate cancer detection in a clinical urological practice by ultrasono-graphy, digital rectal examination and prostate-specific antigen
5. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men
6. Recent progress in ultrasono-graphy of the bladder and prostate
7. Prostatic evaluation by transrectal ultrasonography: Criteria for diagnosis of early carcinoma
8. Use of transrectal ultrasound and prostate specific antigen in diagnosis of prostatic intraepithelial neoplasia
9. Ultrasound-guided and digitally guided biopsies of the prostate
10. Evaluation of transrectal ultrasound in the early detection of prostate cancer
11. Pathologic basis of the sonographic appearance of normal and malignant prostate
12. The significance of isoechoic prostatic carcinoma
13. Prostate cancer: Comparison of transrectal ultrasound and digital rectal examination for screening
14. Transrectal ultrasound and prostate biopsy
15. Efficacy of transrectal ultrasound for identification of clinicaly undetected prostate cancer
16. Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: A preliminary report
17. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
18. Systematic sextant biopsies in 651 patients referred for prostate evaluation
19. Systematic prostatic biopsies in 100 men with no suspicion of prostate cancer on digital rectal examination
20. Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer
21. The sextant biopsy protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer
22. Zonal distribution of prostatic adenocarcinoma: Correlation with histologic pattern and direction of spread
23. Making the most out of six systematic sextant biopsies
24. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection
25. Systematic five region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate
26. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer
27. Diagnostic value of ten systematic TRUS-guided prostate biopsies
28. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial
29. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate
30. Detecting Early Prostate Cancer
31. Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer
32. Value of systematic transition zone biopsies in the early detection of prostate cancer
33. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated
34. Value of routine transition zone biopsies in patients undergoing ultrasound-guided sextant biopsies for the first time
35. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer
36. Differences in location of prostate cancer between African Americans and Caucasians in radical prostatectomy specimens
37. Results of transition zone biopsy in black and white men with suspected prostate cancer
38. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values
39. Indications for transition zone biopsy in the detection of prostatic carcinoma
40. Transrectal ultrasonography in stage A prostate cancer: Detection of residual tumour after TURP
41. Diagnostic yield of extended core biopsies of the lateral peripheral zone and transition zone in the detection of prostate cancer
42. Significance of high-grade prostatic intraepithelial neoplasia (PIN) on needle biopsy
43. Repeat prostate needle biopsy: Who needs it?
44. FolIow-up of atypical prostate needle biopsies suspicious for cancer
45. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathological diagnoses and prostate-specific antigen levels
46. Elevated serum prostate specific antigen levels in conjunction with an initial biopsy negative for carcinoma: Who should undergo a repeat biopsy?
47. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate
48. The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer
49. Bioimpedance: Novel use of a minimally invasive technique for cancer localisation in the intact prostate
50. Artificial neural network analysis (ANNA) of prostatic transrectal ultrasound
51. Latent carcinoma of the prostate
52. Early detection of prostate cancer
53. Probabilities of eventually developing or dying of cancer - United States 1985
54. Localized prostate cancer: Relationship of tumor volume to clinical significance for treatment of prostate cancer
55. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests
56. Pathologic and clinical findings to predict tumour extent of non-paIpable (Stage T1c) prostate cancer
57. Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies
58. Prospective evaluation of men with stage T1c adenocarcinoma of the prostate
59. The nature of prostate cancer detected through prostate specific antigen based screening
60. Pain and morbidity of transrectal ultrasound guided prostate biopsy: A prospective randomised trial of 6 versus 12 cores
61. Periprostatic local anesthesia before ultra-sound guided prostate biopsy
62. Transrectal examination of the prostate: Complications and acceptance by patients
63. Multiple transrectal ultrasound-guided prostatic biopsies-true morbidity and patient acceptance
64. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies
65. Transrectal biopsy of the prostate and bacteraemia
66. Prostatic abscess after transrectal ultrasound guided biopsy
67. Iatrogenic urinary tract infection with pseudomonas cepacia after transrectal ultrasound guided needle biopsy of the prostate
68. Risks and complications of transrectal ultrasound guided prostate needle biopsy: A prospective study and review of the literature
69. Transrectal ultrasound guided biopsy - Defining a new standard